Mdm2 widens its repertoire

Cell Cycle

Volumn 6, Issue 7, 2007, Pages 827-829

  Coutts, Amanda S ^a   La Thangue, Nicholas B ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Co factor JMY; DNA damage; Mdm2; p53; Ubiquitination

Indexed keywords

PROTEASOME; PROTEIN MDM2; PROTEIN P53; UBIQUITIN;

APOPTOSIS; CELL CYCLE ARREST; DNA REPAIR; DNA SYNTHESIS; HUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SENESCENCE; SHORT SURVEY; TRANSCRIPTION REGULATION;

EID: 34147187341     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.7.4086     Document Type: Short Survey

References (22)

1. Vousden KH, Lu X. Live or let die: The cell's response to p53. Nat Rev Cancer 2002; 2:594-604.
2. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31.
3. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994; 22:3551-5.
4. Ljungman M, Lane DP. Transcription - Guarding the genome by sensing DNA damage. Nat Rev Cancer 2004; 4:727-37.
5. Meek DW. The p53 response to DNA damage. DNA Repair (Amst) 2004; 3:1049-56.
6. Lu X. p53: A heavily dictated dictator of life and death. Curr Opin Genet Dev 2005; 15:27-33.
7. Toledo F, Wahl GM. Regulating the p53 pathway: In vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6:909-23.
8. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 2006; 13:941-50.
9. Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci 1999; 55:96-107.
10. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000; 275:8945-51.
11. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9.
12. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303.
13. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4:793-805.
14. Coutts AS, La Thangue NB. The p53 response: Emerging levels of co-factor complexity. Biochem Biophys Res Commun 2005; 331:778-85.
15. Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001; 114:2363-73.
16. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 1998; 2:405-15.
17. Zhu Q, Yao J, Wani G, Wani MA, Wani AA. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: Evidence for the role of p300 in integrating ubiquitination and proteolysis. J Biol Chem 2001; 276:29695-701.
18. Shikama N, Lee CW, France S, Delavaine L, Lyon J, Krstic-Demonacos M, La Thangue NB. A novel co-factor for p300 that regulates the p53 response. Mol Cell 1999; 4:365-76.
19. Demonacos C, Krstic-Demonacos M, La Thangue NB. A TPR motif co-factor contributes to p300 activity in the p53 response. Mol Cell 2001; 8:71-84.
20. Demonacos C, Krstic-Demonacos M, Smith L, Xu D, O'Connor DP, Jansson M, La Thangue NB. A new effector pathway links ATM kinase with the DNA damage response. Nat Cell Biol 2004; 6:968-76.
21. Coutts AS, Boulahbel H, Graham A, La Thangue NB. Mdm2 targets the p53 transcription co-factor JMY for degradation. EMBO Rep 2007; 8:84-90.
22. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 2003; 300:342-4.